Bone infection, also known as osteomyelitis, is a serious condition characterized by the inflammation or infection of bone tissue. This can result from bacteria entering the bone through open fractures, surgical procedures, or bloodstream infections. Common causative bacteria include Staphylococcus aureus. Symptoms of bone infection may include localized pain, swelling, redness, and limited joint mobility. Systemic symptoms like fever and chills can also occur. Chronic or untreated cases may lead to bone destruction and the formation of abscesses. Diagnosis involves medical imaging, blood tests, and sometimes bone biopsies to identify the causative bacteria. Treatment typically includes prolonged courses of antibiotics, and in severe cases, surgical intervention may be necessary to remove infected tissue. Risk factors for bone infections include diabetes, immunocompromised conditions, and the presence of prosthetic devices. Preventive measures involve proper wound care, infection control practices during surgery, and managing underlying health conditions. Early detection and appropriate treatment are essential in managing bone infections and preventing complications. A multidisciplinary approach involving orthopedic surgeons and infectious disease specialists is often required for optimal outcomes.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States